Neha Pagidipati, MD

Assistant Professor of Medicine
Member of the Duke Clinical Research Institute
Email address neha.pagidipati@duke.edu

Neha J. Pagidipati, MD, MPH, is an Assistant Professor of Medicine and cardiovascular disease prevention specialist.  Since 2011, she has conducted research on cardiometabolic disease prevention, lifestyle modification and weight management.  She is currently an NIH K12 scholar in Implementation and Dissemination Science. 

Dr. Pagidipati is building the Duke Cardiometabolic Disease Prevention Program, which focuses on behavior change and risk factor management in patients with high risk of cardiovascular and metabolic diseases such as diabetes and obesity.  The program’s multi-disciplinary team of cardiologists, endocrinologists, nephrologists, and hepatologists will work together to provide coordinated, team-based care to the most high-risk and complex patients in the health system. 

Dr. Pagidipati’s research grants include the COORDINATE-Diabetes Trial, to improve the quality of care for patients with diabetes and cardiovascular disease across the U.S., and QuBBD:  Deep Poisson Methods for Biomedical Time-to-Event and Longitudinal Data.  She served as a study clinician on the large, longitudinal EXSCEL (Exenatide Study of Cardiovascular Event Lowering) trial.  She is currently conducting a nation-wide study of obesity management using real-world data sources, and is a site investigator for the Baseline Health Study in collaboration with Verily Life Sciences. In addition, she is leading a large study within the Duke Health System to study heterogeneity within cardiovascular disease risk and response to weight loss interventions among individuals with obesity. 

Dr. Pagidipati graduated from Harvard College and Harvard Medical School.  She completed her internal medicine residency at Brigham and Women’s Hospital.  During a two-year research fellowship in Global Women’s Health at the Brigham, she obtained an MPH from the Harvard School of Public Health and studied cardiovascular disease prevention in women in India.  Dr. Pagidipati completed a four-year cardiology fellowship at the Duke University School of Medicine and served as Chief Research Fellow at the Duke Clinical Research Institute.  In 2017, she became a faculty member of the Duke University School of Medicine School. 

Education and Training

  • Cardiology Fellowship, Medicine, Duke University School of Medicine, 2013 - 2017
  • Global Women's Health Fellowship, Brigham and Women's Hospital, 2011 - 2013
  • Intership and Residency in Internal Medicine, Brigham and Women's Hospital, 2008 - 2011
  • M.P.H., Harvard University , 2013
  • M.D., Harvard Medical School, 2008

Publications

White, Harvey D., Gregory G. Schwartz, Michael Szarek, Deepak L. Bhatt, Vera A. Bittner, Chern-En Chiang, Rafael Diaz, et al. “Alirocumab after acute coronary syndrome in patients with a history of heart failure.” Eur Heart J 43, no. 16 (April 19, 2022): 1554–65. https://doi.org/10.1093/eurheartj/ehab804.

PMID
34922353
Full Text

Kolossváry, Márton, Thomas Mayrhofer, Maros Ferencik, Júlia Karády, Neha J. Pagidipati, Svati H. Shah, Michael G. Nanna, et al. “Are risk factors necessary for pretest probability assessment of coronary artery disease? A patient similarity network analysis of the PROMISE trial.” J Cardiovasc Comput Tomogr, March 26, 2022. https://doi.org/10.1016/j.jcct.2022.03.006.

PMID
35393245
Full Text

Nelson, Adam J., Emily C. O’Brien, Lisa A. Kaltenbach, Jennifer B. Green, Renato D. Lopes, Caryn G. Morse, Hussein R. Al-Khalidi, et al. “Use of Lipid-, Blood Pressure-, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease.” Jama Netw Open 5, no. 2 (February 1, 2022): e2148030. https://doi.org/10.1001/jamanetworkopen.2021.48030.

PMID
35175345
Full Text

Rao, Vishal N., Michelle D. Kelsey, Michael A. Blazing, Neha J. Pagidipati, Terry A. Fortin, and Marat Fudim. “Unexplained Dyspnea on Exertion: The Difference the Right Test Can Make.” Circ Heart Fail 15, no. 2 (February 2022): e008982. https://doi.org/10.1161/CIRCHEARTFAILURE.121.008982.

PMID
35038884
Full Text

Pagidipati, Neha J., Matthew Phelan, Courtney Page, Megan Clowse, Ricardo Henao, Eric D. Peterson, and Benjamin A. Goldstein. “The importance of weight stabilization amongst those with overweight or obesity: Results from a large health care system.” Prev Med Rep 24 (December 2021): 101615. https://doi.org/10.1016/j.pmedr.2021.101615.

PMID
34976671
Full Text

Samsky, Marc D., Robert J. Mentz, Amanda Stebbins, Yuliya Lokhnygina, Aaron W. Aday, Neha J. Pagidipati, W Schuyler Jones, et al. “Polyvascular disease and increased risk of cardiovascular events in patients with type 2 diabetes: Insights from the EXSCEL trial.” Atherosclerosis 338 (December 2021): 1–6. https://doi.org/10.1016/j.atherosclerosis.2021.10.011.

PMID
34741929
Full Text

Rao, Vishal N., Evan Murray, Javed Butler, Lauren B. Cooper, Zachary L. Cox, Mona Fiuzat, Jennifer B. Green, et al. “In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Reduced Ejection Fraction.” J Am Coll Cardiol 78, no. 20 (November 16, 2021): 2004–12. https://doi.org/10.1016/j.jacc.2021.08.064.

PMID
34763778
Full Text

Taron, Jana, Borek Foldyna, Thomas Mayrhofer, Michael T. Osborne, Nandini Meyersohn, Daniel O. Bittner, Stefan B. Puchner, et al. “Risk Stratification With the Use of Coronary Computed Tomographic Angiography in Patients With Nonobstructive Coronary Artery Disease.” Jacc Cardiovasc Imaging 14, no. 11 (November 2021): 2186–95. https://doi.org/10.1016/j.jcmg.2021.03.019.

PMID
33865792
Full Text

Weissler, E Hope, Robert M. Clare, Yuliya Lokhnygina, John B. Buse, Shaun G. Goodman, Brian Katona, Nayyar Iqbal, et al. “Predicting major adverse limb events in individuals with type 2 diabetes: Insights from the EXSCEL trial.” Diabet Med 38, no. 10 (October 2021): e14552. https://doi.org/10.1111/dme.14552.

PMID
33690915
Full Text

Pages